Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use FROVATRIPTAN SUCCINATE TABLETS safely and effectively. See full prescribing information for FROVATRIPTAN SUCCINATE TABLETS. FROVATRIPTAN SUCCINATE tablets, for oral useInitial U.S. Approval: 2001
Medication labelWhy this: Advisory · dailymed-prescription
Frovatriptan succinate tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use •Use only if a clear diagnosis of migraine has been established. If a patient has no response for the first migraine attack treated with frovatriptan succinate tablets, reconsider the diagnosis of migraine before frovatriptan succinate tablets are administered to treat any subsequent attacks. •Frovatriptan succinate tablets are not indicated for the prevention of migraine attacks. •Safety and effectiveness of frovatriptan succinate tablets have not been established for cluster headache.
- generic_name
- frovatriptan succinate
- product_names
- frovatriptan succinate
- ndc
- 68462-694, 68462-694-97
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en